Regeneron Pharmaceuticals total liabilities and share holders equity for the quarter ending June 30, 2024 was $36.087B, a 17.71% increase year-over-year.
Regeneron Pharmaceuticals total liabilities and share holders equity for 2023 was $33.08B, a 13.23% increase from 2022.
Regeneron Pharmaceuticals total liabilities and share holders equity for 2022 was $29.215B, a 14.86% increase from 2021.
Regeneron Pharmaceuticals total liabilities and share holders equity for 2021 was $25.435B, a 48.19% increase from 2020.
Regeneron Pharmaceuticals Total Liabilities and Share Holders Equity 2010-2024 | REGN